Maarten L.
- Country
- Belgium
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 7 of 73 partner sites.
Specializations
Thoracic Oncology
The investigator specializes in treating limited-stage small cell lung cancer (LS-SCLC), with particular focus on developing therapeutic strategies for previously untreated patients.
- Early-stage lung cancer management
- Treatment-naïve patient care
- Thoracic malignancies
Primary expertise lies in integrating concurrent chemoradiation therapy approaches for thoracic cancers.
Immunotherapy Applications
The investigator focuses on innovative applications of immunotherapeutic agents in lung cancer treatment protocols, particularly exploring the role of pembrolizumab in combination therapies.
- Cancer immunotherapy
- Combination treatment strategies
- Novel therapeutic approaches
Expertise includes integration of targeted therapies with conventional treatment modalities.
Precision Medicine
The investigator explores the therapeutic potential of targeted therapies including PARP inhibitors such as olaparib in lung cancer treatment.
- Targeted therapeutic approaches
- Biomarker-driven treatments
- Personalized medicine strategies
Specialized focus on developing personalized treatment protocols for lung cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.